JOURNAL ARTICLE

US Labels State-Licensed Marijuana as Less Dangerous Drug.

  • Published In: Bloomberg.com, 2026. P. N.PAG 1 of 3

  • Database: Business Source Ultimate 2 of 3

  • Authored By: Strohm, Chris 3 of 3

Abstract

The article focuses on the U.S. Justice Department's reclassification of state-licensed marijuana products from Schedule I to Schedule III under the Controlled Substances Act, a change signed by acting Attorney General Todd Blanche. This shift reduces federal restrictions on marijuana, potentially increasing legal cannabis sales and facilitating more clinical research, though it does not legalize recreational use nationwide. The Department of Justice also announced a June 29 hearing by the Drug Enforcement Administration (DEA) to consider broader rescheduling of marijuana. The move aligns with directives from President Donald Trump and follows stalled efforts under the Biden administration, impacting cannabis businesses and political dynamics. [Extracted from the article]

Additional Information

  • Source:Bloomberg.com. 2026/04, pN.PAG
  • Document Type:Article
  • Subject Area:Political Science
  • Publication Date:2026
  • Accession Number:193223964
  • Copyright Statement:Copyright of Bloomberg.com is the property of Bloomberg, L.P. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.